Market Tracker

05/02 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

33.00
Delayed Data
As of 3:59pm ET
 +0.70 / +2.17%
Today’s Change
16.64
Today|||52-Week Range
51.99
-7.43%
Year-to-Date

Today’s Trading

Previous close32.30
Today’s open34.16
Day’s range30.58 - 34.25
Volume8,115,438
Average volume (3 months)2,866,727
Market cap$3.6B
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)+0.42%
Earnings growth (next 5 years)+73.60%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book16.48

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-0.34-0.23%
NBIXNeurocrine Bioscienc...+1.13+2.48%
GRFSGrifols SA+0.18+1.15%
CBPOChina Biologic Produ...+3.43+2.93%
Data as of 3:59pm ET, 05/02/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts